Glucagon is a pancreatic hormone that plays a crucial role in regulating glucose and whole-body energy metabolism. In individuals with diabetes, the pancreatic alpha cells that produce glucagon are ...

Our findings suggest that GLP-1 therapy holds real promise. While a randomized trial is still needed, the fact that many patients with IIH already qualify for GLP-1s due to diabetes or obesity means ...

In this randomized clinical trial, a low-cost digital intervention increased expectation to adopt health behaviors among adults using glucagon-like peptide-1 receptor agonists (GLP-1RAs), with effects ...

With the rise of glucagon-like-peptide-1 receptor agonist medications (GLP-1RA) for obesity treatment, understanding diet quality can be a valuable tool for providing evidence-based nutrition guidance ...

Indianapolis-based pharma giant Eli Lilly has announced the company now offers an Android version of its app, called Glucagon, which is designed to help caregivers and providers treat people with ...

In early 2025, around 4.9 million British adults — almost one in ten — are estimated to have recently used, or expressed interest in using, glucagon-like peptide-1 (GLP-1) or dual ...

Xeris Biopharma Holdings has received regulatory approval for a new use of its Gvoke liquid glucagon in gastrointestinal radiologic exams, expanding the product's sales base beyond diabetic patients ...

STOCKHOLM — A closed-loop insulin-delivery system, dubbed the 'artificial beta cell,' improved glucose control and reduced hypoglycemia compared with sensor-augmented insulin-pump therapy in patients ...

CHICAGO--(BUSINESS WIRE)-- Xeris Biopharma Holdings, Inc. (XERS), a growth-oriented biopharmaceutical company committed to improving patient lives by developing and commercializing innovative products ...

(HealthDay News) — For patients with type 2 diabetes, once-daily treatment with the glucagon receptor antagonist LY2409021 is associated with increases in ambulatory blood pressure (BP), according to ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Use of glucagon-like peptide-1 receptor agonists among ...